Abstract:Background: Estrogen deficiency causes mitochondrial defects that precede pathological changes related to Alzheimer's disease (AD) in the mouse model of postmenopause. The aim of this study was to investigate in such a mouse model whether and how estrogen receptor beta (ER beta) was involved in prevention of mitochondrial damage and protection of neurons in the hippocampus.Methods: A mouse model of postmenopausal AD was created by ovariectomizing female 3xTg-AD mice, some of which were subcutaneously injected for six weeks with the non-steroidal ER beta agonist diarylpropionitrile. ER beta expression in female C57BL/6J mice was knocked down using shRNA interference. The different groups of animals were compared in terms of cognitive function using the Y-maze test, new object recognition test, and Morris water maze test, expression of numerous proteins related to mitochondrial biogenesis, mitophagy, apoptosis, and mitochondrial membrane potential, as well as deposition of amyloid beta and neurofibrillary tangles. To complement these in vivo studies, we probed the effects of diarylpropionitrile on ER beta expression, apoptosis, and mitochondrial homeostasis in primary rat hippocampal neurons treated with amyloid beta.Results: ER beta knockdown in C57BL/6J mice produced cognitive impairment, reduced mitochondrial biogenesis by downregulating PGC-1 alpha, NRF1, mtTFA, and TOM20, and decreased mitophagy by downregulating Pink1, Parkin, and LC3B while upregulating PARIS and p62. ER beta knockdown promoted neuronal apoptosis by upregulating Cleaved-Caspase 9, Cleaved-Caspase 3, and Bax, while downregulating Bcl2 in hippocampus. Diarylpropionitrile mitigated cognitive decline in ovariectomized 3xTg-AD mice, which was associated with downregulation of BACE1, reduction of A beta deposition, neurofibrillary tangles, and tau hyperphosphorylation, and upregulation of ER beta, increases in mitochondrial biogenesis and mitophagy, and decreases in apoptosis. The effects of diary-lpropionitrile in mice were recapitulated in A beta-injured primary rat hippocampal neurons.Conclusions: ER beta activation can support learning and memory and alleviate AD symptoms in the postmenopausal AD model, which may involve regulation of neuronal mitochondrial biogenesis and mitophagy via NRF1/PGC-1 alpha. This study supports further research on ER beta as a therapeutic target for postmenopausal women with AD.

Estradiol Attenuates Tau Hyperphosphorylation Induced by Upregulation of Protein Kinase-A

17 Beta-Estradiol Attenuates Glycogen Synthase Kinase-3 Beta Activation And Tau Hyperphosphorylation In Akt-Independent Manner

Expression of the Hyperphosphorylated Tau Attenuates ER Stress-Induced Apoptosis with Upregulation of Unfolded Protein Response

Estrogen Stimulates Degradation of Beta-Amyloid Peptide by Up-Regulating Neprilysin

Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.

The role of estrogen in Alzheimer's disease pathogenesis and therapeutic potential in women

β2 Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models

The Inhibition of Estrogen on OA-induced SH-SY5Y Hyperphosphorylation of Tau Protein

Estrogen Stimulates Release of Secreted Amyloid Precursor Protein from Primary Rat Cortical Neurons Via Protein Kinase C Pathway.

Overexpression of Estrogen Receptor Beta Alleviates the Toxic Effects of Beta-Amyloid Protein on PC12 Cells Via Non-Hormonal Ligands

Estrogen Receptor Β Exerts Neuroprotective Effects by Fine-Tuning Mitochondrial Homeostasis Through NRF1/PGC-1α

Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.

Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells

Raloxifene alleviates amyloid-β-induced cytotoxicity in HT22 neuronal cells via inhibiting oligomeric and fibrillar species formation.

Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides

Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice

Naringin Protects against Tau Hyperphosphorylation in Aβ25–35-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways

Hormonal Control of Cerebral Amyloidogenesis in Alzheimer'S Diseases